Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man

European Journal of Clinical Investigation

Volumn 27, Issue 1, 1997, Pages 10-16

  Shalev, A ^a   Holst, J J ^b   Keller, U ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Energy expenditure; Glucose clamping; Leucine kinetics; Somatostatin

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; INSULIN;

ADULT; ARTICLE; CALORIMETRY; CONTROLLED STUDY; ENERGY EXPENDITURE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM;

EID: 0031049302     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.540613.x     Document Type: Article

References (30)

1. Bell GI, Santerre RF, Mullenbach GT. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 1983;302:716-18.
2. Orskov C, Holst JJ, Knuhtsen S, Baldissera FG, Poulsen SS, Nielsen OV. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine hut not pancreas. Endocrinology 1986;119: 1467-75.
3. Hartmann B, Orskov C, Wettergren A, Holst JJ. Diurnal profiles of glucagon-like peptides 1 and 2 (GLP-1 and GLP-2) in normal man (abstract). Diabetologia 1995;38(Suppl.1):A167.
4. Orskov C, Bersani M, Johnsen AH, Hojrup P, Holst JJ. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J Biol Chem 1989;264:12826-9.
5. Holst JJ, Orskov C, Nielsen OV, Schwartz TW. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 1987;211:169-74.
6. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987;2: 1300-4.
7. Fehmann HC, Habener JF. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-I cells. Endocrinology 1992;130:159-66.
8. Göke R, Wagner B, Fehmann HC, Göke B. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1(7-36) amide on the rat pancreas. Res Exp Med Berl 1993;193: 97-103.
9. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993;36:741-4.
10. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus [see comments]. N Engl J Med 1992;326:1316-22.
11. Tessari P, Biolo G, Inchiostro S et al. Effects of insulin on whole body and forearm leucine and KIC metabolism in type 1 diabetes. Am J Physiol 1990;259:E96-E103.
12. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 1983;25:400-3.
13. Fukagawa NK, Minaker KL, Rowe JW et al. Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J Clin Invest 1985;76:2306-11.
14. Ruiz-Grande C, Alacron C, Merida E, Valverde I. Lipolytic action of glucagon-like peptides in isolated rat adipocytes. Peptides 1992;13:13-16.
15. Wolfe RR. Protein Synthesis and Breakdown: Radioactive and Stable Isotope tracers in Biomedicine. New York: J Wiley & Sons, 1992;377-416.
16. Hood VL, Keller U, Haymond MW, Kury D. Systemic pH modifies ketone body production rates and lipolysis in humans. Am J Physiol 1990;259:E327-E334.
17. Allsop JR, Wolfe RR, Burke JF. Tracer priming the bicarbonate pool. J Appl Physiol 1978;45:137-9.
18. Abumrad NN, Rabin D, Diamond MP, Lacy WW. Use of heated superficial handvein as alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metab Clin Exp 1981;30:936-40.
19. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W. Preseved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 1993;91:301-7.
20. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
21. Horber FF, Horber-Feyder CM, Krayer S, Schwenk WF, Huymond MW. Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis. Am J Physiol 1989:257:E385-E399.
22. Laager R, Ninnis R, Keller U. Comparison of the effects of recombinant human insulin-like growth factor-1 and insulin on glucose and leucine kinetics in humans. J Clin Invest 1993;92: 903-9.
23. Miles J, Glasscock R, Aikens J, Gerich J, Haymond M. Micro-fluorometric method for the determination of free fatty acids in plasma. J Lipid Res 1983;24:96-9.
24. Chernick SS. Determination of glycerol in acyl glycerols. Methods Enzymol 1969;14:627-30.
25. Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ. Tissue and plasma concentrations of umidated and glycine-extended glucagon-like peptide1 in humans. Diabetes 1994;43:535-9.
26. Castellino P, Luzi L, Simonson DC, Haymond M, DeFronzo RA. Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J Clin Invest 1987;80:1784-93.
27. Vollenweider P, Tappy L, Randin D et al. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 1993;92:147-54.
28. Christin L, Nacht CA, Vernet O, Ravussin E, Jéquier E, Acheson KJ. Insulin: its role in the thermic effect of glucose. J Clin Invest 1986; 77:1747-55.
29. Jensen MD, Caruso M, Heiling V, Miles JM. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 1989;38: 1595-1601.
30. Orskov C, Holst JJ, Nielsen OV. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology 1988;123:2009-13.